Le Lézard
Classified in: Covid-19 virus
Subject: Economic News/Analysis

Best's Market Segment Report: AM Best Revises Outlook on Indonesia's Non-Life Insurance Market to Negative


AM Best has revised its market segment outlook on Indonesia's non-life insurance market to negative from stable, citing a weaker-than-expected economy recovery, which likely will delay the segment's recovery to pre-pandemic growth levels, along with the increased likelihood of depressed investment returns and heightened credit insurance risks.

The Best's Market Segment Report, "Market Segment Outlook: Indonesia Non-Life Insurance," notes that a resurgence of the COVID-19 virus, coupled with slow vaccination progress, has led to a reinstatement of stringent mobility restrictions, hampering near-term economic recovery. Weaknesses in the economy and the potential inability to contain the pandemic could mute insurance demand in a number of product lines, such as property, engineering, motor, transportation and travel insurance. Although premium income increased by approximately 2% to IDR 38.5 trillion (USD 2.74 billion) in the first half of 2021, compared with the same prior-year period, the growth lagged behind pre-pandemic levels, and may remain constrained as a result of the latest round of mobility restriction measures.

Credit insurance, a key line of business in Indonesia's non-life insurance market, is under pressure as well with further economic weaknesses arising from the escalation of COVID-19 infections. This could weaken the debt repayment abilities of debtors and lead to higher default rates, and therefore, higher credit insurance claims, particularly for the more vulnerable small and medium-sized enterprises. Insurers with higher exposure to credit insurance and weaker underwriting risk management may face outsized losses that could weaken their financial profile.

The low interest rate environment also continues to impede the investment performance of Indonesia's non-life insurers. The report states that investment risks could trend higher as prolonged pandemic conditions erode the financial strength and earnings abilities of debt and equity issuers.

AM Best expects the mandatory tariffs within the non-life insurance market for property - including business interruption - and motor lines of business to remain a supportive element of the market. The mandatory tariffs for these lines of business has helped to limit the level of unhealthy price competition often seen in other liberalised markets. Additionally, greater investment in and usage of technology to support improvements in distribution and operational efficiency should help Indonesia's non-life carriers achieve competitive advantages over the medium to long term.

To access the full copy of this report, please visit http://www3.ambest.com/bestweek/purchase.asp?record_code=312882.

AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2021 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.


These press releases may also interest you

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...



News published on and distributed by: